Literature DB >> 29884422

Medical, psychosocial, and treatment predictors of opioid overdose among high risk opioid users.

Samantha Schiavon1, Kathleen Hodgin2, Aaron Sellers3, Margaret Word4, James W Galbraith5, John Dantzler6, Karen L Cropsey7.   

Abstract

INTRODUCTION: Drug overdoses are the leading cause of accidental death in the United States. It is imperative to explore predictors of opioid overdose in order to facilitate targeted treatment and prevention efforts. The present study was conducted as an exploratory examination of the factors associated with having a past opioid overdose.
METHODS: Participants (N = 244) from substance treatment facilities, inpatient services following ER admittance, or involved within the drug court system and who reported opioid use in the past 6 months were recruited in this study. Measures of opioid use and history were used to determine characteristics associated with previous experience of a non-fatal opioid overdose.
RESULTS: Opioid users who were Caucasian and used a combination of prescription opioids and heroin were more likely to have experienced a prior overdose. Opioid user characteristics associated with greater odds of experiencing a prior overdose included: witnessing a friend overdose (OR 4.21), having chronic hepatitis C virus (HCV) infection (OR 2.44), reporting a higher frequency of buprenorphine treatment episodes (OR 1.55), and having a higher frequency of witnessing others overdose (OR 1.42). Greater frequency of methadone treatment episodes was related to decreased odds of experiencing an overdose (OR 0.67).
CONCLUSION: Overall, this study demonstrated certain demographic and drug use factors associated with elevated risk for an overdose. Understanding the risk factors associated with drug overdose can lead to targeted naloxone training and distribution to prevent fatal overdoses.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Medical risk; Opioids; Overdose; Psychosocial risks; Treatment risk

Mesh:

Substances:

Year:  2018        PMID: 29884422     DOI: 10.1016/j.addbeh.2018.05.029

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  3 in total

1.  Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018.

Authors:  Priya Jain; Kimberley McKinnell; Rose Marino; Prashanthi Vunnava; Marie A Liles-Burden; Avani Desai; Madé Wenten; James Fratantonio; Sarah C Akerman; Maria A Sullivan; Gary Bloomgren
Journal:  Drug Saf       Date:  2020-11-30       Impact factor: 5.606

2.  Prevalence of Mental Health Disorders among Individuals Enrolled in an Emergency Response Program for Treatment of Opioid Use Disorder.

Authors:  Christine Bakos-Block; James R Langabeer; Andrea Yatsco; Marylou Cardenas-Turanzas; Tiffany Champagne-Langabeer
Journal:  Subst Abuse       Date:  2020-12-21

3.  Engagement in Harm Reduction Strategies After Suspected Fentanyl Contamination Among Opioid-Dependent Individuals.

Authors:  Colleen B Mistler; Divya K Chandra; Michael M Copenhaver; Jeffrey A Wickersham; Roman Shrestha
Journal:  J Community Health       Date:  2020-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.